Format

Send to

Choose Destination
See comment in PubMed Commons below
Ugeskr Laeger. 1991 Oct 21;153(43):2999-301.

[Pneumococcal vaccination of splenectomized patients. Recommendations based on a 10-year experience].

[Article in Danish]

Author information

1
Bakteriologisk afdeling, Statens Seruminstitut, KĂžbenhavn.

Abstract

In 1978, pneumococcal vaccination in splenectomized patients over the age of two years was introduced in Denmark. Since then, no cases of pneumococcal bacteraemia or meningitis have occurred in splenectomized children. Prior to introduction of vaccination, infections of this nature occurred with an incidence of approximately 4%. We have investigated the duration of the vaccine-induced increase in antibodies in splenectomized children and adults and, on this basis, we recommend that all children vaccinated in the age group 2-14 years should have pneumococcal antibodies measured five years after vaccination because the antibodies in a number of the children will have decreased to such an extent that revaccination is necessary. All patients who were over 14 years on vaccination should, until further notice, have the pneumococcal antibodies measured after ten years although we have found that 2, 5, 7 and 10 years after vaccination, the antibody level had only decreased to 71, 69, 70 and 63% of the antibody concentrations obtained by pneumococcal vaccination.

PMID:
1801383
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center